Reposted by Charalampos (Harris) Lazaris, Ph.D.Keystone Symposia @keystonesymposia.bsky.social · 30/09/2026🧬 Our joint meeting Precision Genome Engineering + Targeted Delivery of Nucleic Acid Medicines (Jan 25–28, Keystone) cover genome editing, delivery innovations & clinical translation. Short talk abstracts + $1500 scholarships close TOMORROW (Oct 1). Apply now: hubs.la/Q04xVtQN0 hubs.la/Q04xVv0z0 022
Reposted by Charalampos (Harris) Lazaris, Ph.D.Keystone Symposia @keystonesymposia.bsky.social · 01/10/2026⏰ Deadline extended to Oct 14: scholarships + short talk abstracts for Genetic Medicines to Treat Cardiovascular Disease 📍 Keystone, CO | Jan 25–28, 2027 hubs.la/Q04xTx2d0 🎥 James Ware on what to expect Joint w/ 2 meetings on genome engineering & nucleic acid delivery 012
Reposted by Charalampos (Harris) Lazaris, Ph.D.Keystone Symposia @keystonesymposia.bsky.social · 25/09/2026Read Dr. Chaim's Fellow Spotlight: keypoint.keystonesymposia.org/home/keyston...keypoint.keystonesymposia.orgKeystone Symposia Fellow Spotlight: Dr. Alex ChaimDiscover why Keystone Symposia's Fellow Dr. Alex Chaim was inspired to study RNA damage, his recent milestones, and his dedication to science inclusivity. 032
Reposted by Charalampos (Harris) Lazaris, Ph.D.Keystone Symposia @keystonesymposia.bsky.social · 25/09/2026🔬 Meet Alex Chaim, PhD — Keystone Symposia Fellow at UCSD chasing a question the field ignored for 20 years: could damaged RNA be quietly driving Alzheimer's, Parkinson's & cancer? His lab is building the tools to find out. #RNADamage #KeystoneFellows #LatinosInSTEM 222
Reposted by Charalampos (Harris) Lazaris, Ph.D.Keystone Symposia @keystonesymposia.bsky.social · 22/09/2026We are proud to partner with @ludwigcancer.bsky.social on our Tumor and Host Metabolism meeting. Save the date and register today! March 7-10, 2027 at the Ludwig Institute for Cancer Research, Princeton Branch. 022
Reposted by Charalampos (Harris) Lazaris, Ph.D.Aaron Rupar @atrupar.com · 17/09/2026here's footage of Mamdani alongside city workers filling the 200,000th NYC pothole since the start of his term This is part of his push to spotlight city workers and inform New Yorkers that all the fixes they ask for "should be directed to the real heroes, City Workers, who can be reached via 311" 215100541840
Reposted by Charalampos (Harris) Lazaris, Ph.D.Keystone Symposia @keystonesymposia.bsky.social · 17/09/2026🔬 Cancer Immunotherapy: Bridging Basic Research and Clinical Translation (Jan 24–27, Breckenridge). Upcoming deadlines: $1,500 scholarships + short talk abstracts: Sept 29. #KSCancerIO27 #scholarships 122
Reposted by Charalampos (Harris) Lazaris, Ph.D.Keystone Symposia @keystonesymposia.bsky.social · 16/09/2026Apply today: hubs.la/Q04s8Tkx0hubs.laFellows Program | Keystone SymposiaThe Keystone Symposia Fellows program provides training, mentorship and career development opportunities for researchers from underrepresented backgrounds! 021
Reposted by Charalampos (Harris) Lazaris, Ph.D.Keystone Symposia @keystonesymposia.bsky.social · 16/09/2026Are you a postdoc or early-career scientist? The Keystone Symposia Fellows Program may be for you. Career development. SAB meetings with leaders in your field. 1:1 mentorship. A community of Fellows committed to each other's growth. Applications close in 2 weeks on Sept. 28. 134
Reposted by Charalampos (Harris) Lazaris, Ph.D.Keystone Symposia @keystonesymposia.bsky.social · 10/09/2026Read more about our new visual ID in our latest blog: hubs.la/Q04xbtNC0hubs.laA Fresh Look, the Same Foundation: Introducing Keystone Symposia's Updated Visual IdentityKeystone Symposia unveils a refreshed visual identity to enhance its mission of fostering scientific discovery in the life sciences community. 021
Reposted by Charalampos (Harris) Lazaris, Ph.D.Keystone Symposia @keystonesymposia.bsky.social · 10/09/2026This fall, we are rolling out a refreshed visual identity—Designed for Discovery. Because Keystone Symposia doesn't just host 50+ conferences. We design environments that spark collaboration and transform careers. The real story: expanding scholarships, LMIC access, and more. 132
Reposted by Charalampos (Harris) Lazaris, Ph.D.Keystone Symposia @keystonesymposia.bsky.social · 09/09/2026Calling all neuroscientists 🧠 $1500 scholarship app + short talk deadlines are approaching! Sept 22: Sensory Systems + Appetite Control Sept 24: Neurodevelopmental Disorders + Neural Plasticity & Recovery 4 Neuro meetings, 1 week in January, 30 min apart in the CO Rockies. 162
Reposted by Charalampos (Harris) Lazaris, Ph.D.Keystone Symposia @keystonesymposia.bsky.social · 04/09/2026🚨Don't miss this Sept 8th deadline! Global Health Travel Awards are available for travel support to our Reimagining Diabetes conference. 062
Reposted by Charalampos (Harris) Lazaris, Ph.D.Keystone Symposia @keystonesymposia.bsky.social · 01/09/2026📌 Poster abstract deadline for Hormonal Influences on Immunity and Cancer Across the Lifespan: Sept 14. Present your work where endocrinology, immunology & oncology converge — in partnership with @endocrinesociety.bsky.social 🔬 💻 Can't attend in person? Join via livestream! #KSHormoneInflu27 132
Reposted by Charalampos (Harris) Lazaris, Ph.D.Keystone Symposia @keystonesymposia.bsky.social · 01/09/2026⌛️Only 1 more week to apply for a Global Health Travel Award to attend Reimagining Diabetes! Share this with a scientist from a low- and middle-income country who should join us and the @endocrinesociety.bsky.social in Keystone, CO this February. 131
Reposted by Charalampos (Harris) Lazaris, Ph.D.Keystone Symposia @keystonesymposia.bsky.social · 28/07/2026Read @chlazaris.bsky.social full Fellow Spotlight 👇 keypoint.keystonesymposia.org/home/keyston...keypoint.keystonesymposia.orgKeystone Symposia Fellow Spotlight: Dr. Charalampos (Harris) A. LazarisDiscover the inspiring journey of Dr. Charalampos A. Lazaris, a Keystone Symposia Fellow, as he advances cancer research through gene regulation and mentorship. 021
Reposted by Charalampos (Harris) Lazaris, Ph.D.Keystone Symposia @keystonesymposia.bsky.social · 28/07/2026✨ Fellow Spotlight: Dr. Charalampos Lazaris, MBA, PhD @chlazaris.bsky.social Senior Data Scientist at @novartis.bsky.social studying how cancer cells get "hooked" on gene-expression programs — and how those dependencies can be turned against the disease. 🔗 to his full story in replies #KSFellows 222
Reposted by Charalampos (Harris) Lazaris, Ph.D.Keystone Symposia @keystonesymposia.bsky.social · 13/08/2026"A good mentor helps you navigate complex work environments, professional relationships, and career choices in a way that aligns with your values." — Dr. Charalampos Lazaris, KS Fellow & Oncology Data Scientist at @novartis.bsky.social Missed @chlazaris.bsky.social spotlight? Link below 👇 121
Charalampos (Harris) Lazaris, Ph.D. @chlazaris.bsky.social · 07/01/2026Honored to join the Keystone Symposia Fellows Class of 2026! Grateful to @iannisaifantis1, @artsinyc, Matt Shirley & colleagues from @nyugrossman, @WhiteheadInst, and @broadinstitute for their support. Looking forward to what’s ahead! keypoint.keystonesymposia.org/home/welcomi... @KeystoneSympkeypoint.keystonesymposia.orgWelcoming the Keystone Symposia Fellow's Class of 2026!The Keystone Symposia Fellows Class of 2026 is announced, showcasing rising stars in biomedical research across the United States for this formative leadership training program. 000
Charalampos (Harris) Lazaris, Ph.D. @chlazaris.bsky.social · 15/03/2025www.tovima.gr/print/societ...tovima.grΓιατί η Ελλάδα «τρώει» το ερευνητικό δυναμικό της - ΤΟ ΒΗΜΑΤις δομικές αδυναμίες της έρευνας στη χώρα μας και τους λόγους που τους ανάγκασαν να παραιτηθούν από το Εθνικό Συμβούλιο Ερευνας, Τεχνολογίας και Καινοτομίας ανέλυσαν σε διαδικτυακή ημερίδα οι καθηγητ... 010
Reposted by Charalampos (Harris) Lazaris, Ph.D.MIT Koch Institute @mitkochinstitute.bsky.social · 03/03/2025Three cheers for three KI cancer research projects in this year’s #STATMadness. Vote now for revolutionizing chemotherapy, implantable microparticles and early lung cancer detection: Details👇voting 👉 buff.ly/T1VqmBu @statnews.com 011
Reposted by Charalampos (Harris) Lazaris, Ph.D.Nature Reviews Cancer @natrevcancer.nature.com · 19/02/2025#REVIEW 🚨 In our Feb. issue, Wang & Zhang summarize findings from genetic & epigenetic association studies performed on cohorts of survivors of childhood cancer, providing insights into the long-term adverse effects related to cancer therapy. 📖 👇 bit.ly/4eplZ...bit.lyGenetic and epigenetic bases of long-term adverse effects of childhood cancer therapy - Nature Reviews CancerIn this Review, Wang and Zhang summarize the major findings of genetic and epigenetic association studies performed on cohorts of survivors of childhood cancer, which provide insights into the long-term adverse effects related to cancer therapy, and present suggestions.... 074
Charalampos (Harris) Lazaris, Ph.D. @chlazaris.bsky.social · 23/12/2024Explore emerging research with field leaders @KeystoneSymp Epigenetics in Development and Disease, this March in Banff! keysym.us/KSEpigenetics25 #KSEpigenetics25keysym.usEpigenetics in Development and Disease | Keystone SymposiaJoin us at the Keystone Symposia on Epigenetics in Development and Disease, March 2025, in Banff, with field leaders! 010
Reposted by Charalampos (Harris) Lazaris, Ph.D.Ed Yong is offline @edyong209.bsky.social · 08/08/2012Reading: @NatureNews Jay Bradner wants to thwart a cancer driver through epigenetics & he's not shy talking about it. bit.ly/MyyQNhbit.lyCancer research: Open ambition - NatureJay Bradner believes that cancer can be defeated through ... 121
Reposted by Charalampos (Harris) Lazaris, Ph.D.Kyle LaHucik @kylelahucik.bsky.social · 21/11/2024Amgen is getting a new chief scientific officer next month, the famed geneticist Howard Chang, as Jay Bradner splits his rolesendpts.comAmgen names Stanford geneticist and biotech founder to CSO postHoward Chang, Stanford physician-scientist and biotech co-founder, will become Amgen's new chief science officer. 021
Reposted by Charalampos (Harris) Lazaris, Ph.D.Mitch Guttman @mitchguttman.bsky.social · 27/11/2024Gene regulation involves thousands of proteins that bind DNA, yet comprehensively mapping these is challenging. Our paper in Nature Genetics describes ChIP-DIP, a method for genome-wide mapping of hundreds of DNA-protein interactions in a single experiment. www.nature.com/articles/s41...nature.comChIP-DIP maps binding of hundreds of proteins to DNA simultaneously and identifies diverse gene regulatory elements - Nature GeneticsChIP-DIP (ChIP done in parallel) is a highly multiplex assay for protein–DNA binding, scalable to hundreds of proteins including modified histones, chromatin regulators and transcription factors, offe... 9382150
Reposted by Charalampos (Harris) Lazaris, Ph.D.Aaron Quinlan (he/him) @aaronquinlan.bsky.social · 03/12/2024Biology of Genomes 2025 is coming up: - meeting dates: May 6 - 10, 2025 - abstract deadline: Feb 14, 2025 We hope to see you there for another great meeting with a fantastic speaker lineup! meetings.cshl.edu/meetings.asp...meetings.cshl.eduBiology of GenomesCold Spring Harbor Laboratory Meetings & Courses -- a private, non-profit institution with research programs in cancer, neuroscience, plant biology, genomics, bioinformatics. 16634
Reposted by Charalampos (Harris) Lazaris, Ph.D.TruBlu 🌊🌊🌊 @trublu268.bsky.social · 06/12/2024Congrats to Florida! #1 in book censorship #47 in SAT scores. Way to go! #floriduh 1175415916614
Reposted by Charalampos (Harris) Lazaris, Ph.D.Bluesky @bsky.app · 03/12/2024Scientists, academics, researchers: We’re excited to share that @altmetric.com is now tracking mentions of your research on Bluesky! 🧪 456294874995
Reposted by Charalampos (Harris) Lazaris, Ph.D.Dittie @dittie.sheshed.rocks · 02/12/2024The EFJ will stop posting on X as of January 20, 2025. This Federation of journalists has roughly 30,000 members across 44 countries and they join several other news sources in leaving the social media platform. www.thelondoneconomic.com/news/media/e...thelondoneconomic.comEuropean Federation of Journalists to stop posting content on XThe EFJ represents over 295,000 journalists in 44 countries. 22278151140